FIELD: medicine; endocrinology; nephrology and therapy.
SUBSTANCE: invention can be used to predict the risk of a high rate of progression of chronic kidney disease. Such indicators as age, body mass index, duration of diabetes mellitus and insulin therapy, history of acute myocardial infarction, characteristics of popliteal artery pulsation, diagnosis of retinopathy, arterial hypertension risk group, use of sulfonylurea drugs and calcium antagonists are determined. The obtained indicators are assigned points and summarized. According to a given formula, the rate of decrease in glomerular filtration rate (IS_GFR) is determined. And with a score of more than 160 and an indicator of IS_GFR more than 4 ml/min/1.73 m2/year, the risk of a high rate of progression of chronic kidney disease is predicted.
EFFECT: method makes it possible to identify groups at high risk of progression of diabetic kidney damage and allows to prescribe nephroprotective therapy at the preclinical stage of development of chronic kidney disease by assessing the totality of the most significant indicators.
1 cl, 8 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF HIGH RATE OF PROGRESSION OF CHRONIC KIDNEY DISEASE IN ELDERLY PATIENTS WITH CONCOMITANT TYPE 2 DIABETES MELLITUS | 2023 |
|
RU2825048C1 |
METHOD OF PREDICTING RISK OF HIGH RATE OF PROGRESSION OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS USING DIAGNOSTIC INDEX OF REDUCED GLOMERULAR FILTRATION RATE | 2023 |
|
RU2810369C1 |
PREDICTING METHOD FOR DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS (OPTIONS) | 2021 |
|
RU2757522C1 |
METHOD FOR EARLY PREDICTION OF THE RISK OF DEVELOPMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS | 2022 |
|
RU2793531C1 |
METHOD OF EARLY PREDICTION OF RISK OF DEVELOPMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2812643C2 |
METHOD FOR PREDICTING IMPROVEMENT OF RENAL HEMODYNAMICS 6 MONTHS AFTER PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2023 |
|
RU2807270C1 |
METHOD OF ASSESSING EFFECTIVENESS OF NEPHROPROTECTIVE THERAPY IN HYPERTENSIVE PATIENTS WITH STAGE C2 CHRONIC KIDNEY DISEASE | 2023 |
|
RU2810453C1 |
METHOD FOR PREDICTING ADVERSE PREGNANCY OUTCOMES IN WOMEN WITH TYPE 1 DIABETES MELLITUS IN THE SECOND HALF OF PREGNANCY | 2020 |
|
RU2759076C1 |
METHOD FOR DETERMINATION OF THE TREATMENT ONSET BY PROGRAM HEMODIALYSIS OF PATIENTS WITH CKD C5 | 2017 |
|
RU2653819C1 |
METHOD FOR PREDICTING THE EFFECTIVENESS OF NEPHROPROTECTION IN SELECTING THE PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION ASSOCIATED WITH TYPE 2 DIABETES MELLITUS FOR THE SYMPATHETIC RENAL DENERVATION OF RENAL ARTERIES | 2019 |
|
RU2728093C1 |
Authors
Dates
2023-08-22—Published
2022-06-02—Filed